Cured but Not Well - haematological Cancer Survivors' Experiences of Chemotherapy-induced Peripheral Neuropathy in Everyday Life: a Phenomenological-hermeneutic Study

Overview

Journal J Cancer Surviv

Specialty Oncology

Date 2024 May 14

PMID 38743186

Authors

Mette Louise Roed

Marianne Tang Severinsen

Eva Futtrup Maksten

Lone Jorgensen

Helle Enggaard

Affiliations

Soon will be listed here.

Abstract

Purpose: To explore haematological cancer survivors' experience of chemotherapy-induced peripheral neuropathy (CIPN) in everyday life.

Methods: Data were generated by means of individual semi-structured interviews with 12 haematological cancer survivors who experience CIPN after completion of treatment. Data were analysed using thematic analysis.

Results: The thematic analysis yielded an in-depth description of the experience of CIPN symptoms and the influence of the symptoms on everyday life as being unwell despite being cured. Four main themes emerged from the analysis: (1) A diffuse and contradictory sensation which is impossible to ignore in everyday life, (2) Not feeling well, even though I'm cured, (3) Living with CIPN, despite limitations, and (4) An invisible companion, that everybody knows about.

Conclusion: The findings shows that survival from haematological cancer does not always equal well-being, as experiencing CIPN has extensive consequences on everyday life. CIPN affects haematological cancer survivors' transition to an ordinary everyday life, with disturbances in the physical function, daily activities, social relationships, psychological aspects, and work ability. As a diffuse and contradictory symptom, CIPN appears as an invisible companion that leads to a feeling of being alone.

Implications For Cancer Survivors: A better and deeper understanding of haematological cancer survivors' experience of CIPN in everyday life may improve communication, guidance, and treatment of CIPN symptoms. The results suggest a need for interventions and strategies to accommodate the gap in practice and to address the impact of CIPN in everyday life.

Citing Articles

Comfort Care Needs of Allogeneic Stem Cell Transplant Survivors: Lived Experience.

Bacalhau L, Pontifice-Sousa P Healthcare (Basel). 2024; 12(22).

PMID: 39595416 PMC: 11593941. DOI: 10.3390/healthcare12222217.

Applications of Multimodal Artificial Intelligence in Non-Hodgkin Lymphoma B Cells.

Isavand P, Aghamiri S, Amin R Biomedicines. 2024; 12(8).

PMID: 39200217 PMC: 11351272. DOI: 10.3390/biomedicines12081753.

References

Hemminki K, Hemminki J, Forsti A, Sud A . Survival in hematological malignancies in the Nordic countries through a half century with correlation to treatment. Leukemia. 2023; 37(4):854-863. PMC: 10079539. DOI: 10.1038/s41375-023-01852-w. View

Nielsen L, Kristensen D, Jakobsen L, Bogsted M, Gregersen H, Madsen J . Socioeconomic Status and Overall Survival Among Patients With Hematological Malignant Neoplasms. JAMA Netw Open. 2024; 7(3):e241112. PMC: 10912957. DOI: 10.1001/jamanetworkopen.2024.1112. View

Kerckhove N, Collin A, Conde S, Chaleteix C, Pezet D, Balayssac D . Long-Term Effects, Pathophysiological Mechanisms, and Risk Factors of Chemotherapy-Induced Peripheral Neuropathies: A Comprehensive Literature Review. Front Pharmacol. 2017; 8:86. PMC: 5323411. DOI: 10.3389/fphar.2017.00086. View

Jongen J, Broijl A, Sonneveld P . Chemotherapy-induced peripheral neuropathies in hematological malignancies. J Neurooncol. 2014; 121(2):229-37. DOI: 10.1007/s11060-014-1632-x. View

Seretny M, Currie G, Sena E, Ramnarine S, Grant R, Macleod M . Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. Pain. 2014; 155(12):2461-2470. DOI: 10.1016/j.pain.2014.09.020. View

Massey R, Kim H, Abdi S . Brief review: chemotherapy-induced painful peripheral neuropathy (CIPPN): current status and future directions. Can J Anaesth. 2014; 61(8):754-62. DOI: 10.1007/s12630-014-0171-4. View

Beijers A, Vreugdenhil G, Oerlemans S, Eurelings M, Minnema M, Eeltink C . Chemotherapy-induced neuropathy in multiple myeloma: influence on quality of life and development of a questionnaire to compose common toxicity criteria grading for use in daily clinical practice. Support Care Cancer. 2015; 24(6):2411-20. DOI: 10.1007/s00520-015-3032-y. View

Eikeland S, Smeland K, Mols F, Fagerli U, Bersvendsen H, Kiserud C . Chemotherapy-induced peripheral neuropathy after modern treatment of Hodgkin's lymphoma; symptom burden and quality of life. Acta Oncol. 2021; 60(7):911-920. DOI: 10.1080/0284186X.2021.1917776. View

Kim B, Park H, Roh H, Jeong D, Kim B, Park K . Chemotherapy-related polyneuropathy may deteriorate quality of life in patients with B-cell lymphoma. Qual Life Res. 2010; 19(8):1097-103. DOI: 10.1007/s11136-010-9670-0. View

10.

Loprinzi C, Lacchetti C, Bleeker J, Cavaletti G, Chauhan C, Hertz D . Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update. J Clin Oncol. 2020; 38(28):3325-3348. DOI: 10.1200/JCO.20.01399. View

11.

Jordan B, Margulies A, Cardoso F, Cavaletti G, Haugnes H, Jahn P . Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO-EONS-EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up. Ann Oncol. 2020; 31(10):1306-1319. DOI: 10.1016/j.annonc.2020.07.003. View

12.

Bakitas M . Background noise: the experience of chemotherapy-induced peripheral neuropathy. Nurs Res. 2007; 56(5):323-31. DOI: 10.1097/01.NNR.0000289503.22414.79. View

13.

Tofthagen C . Patient perceptions associated with chemotherapy-induced peripheral neuropathy. Clin J Oncol Nurs. 2010; 14(3):E22-8. DOI: 10.1188/10.CJON.E22-E28. View

14.

Neubauer B, Witkop C, Varpio L . How phenomenology can help us learn from the experiences of others. Perspect Med Educ. 2019; 8(2):90-97. PMC: 6468135. DOI: 10.1007/s40037-019-0509-2. View

15.

Debesay J, Naden D, Slettebo A . How do we close the hermeneutic circle? A Gadamerian approach to justification in interpretation in qualitative studies. Nurs Inq. 2008; 15(1):57-66. DOI: 10.1111/j.1440-1800.2008.00390.x. View

16.

Tong A, Sainsbury P, Craig J . Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007; 19(6):349-57. DOI: 10.1093/intqhc/mzm042. View

17.

Andrade C . The Inconvenient Truth About Convenience and Purposive Samples. Indian J Psychol Med. 2021; 43(1):86-88. PMC: 8295573. DOI: 10.1177/0253717620977000. View

18.

Gill P, Stewart K, Treasure E, Chadwick B . Methods of data collection in qualitative research: interviews and focus groups. Br Dent J. 2008; 204(6):291-5. DOI: 10.1038/bdj.2008.192. View

19.

Pedersen B, Jensen M, Yilmaz M, Morch C, Feilberg C . A peculiar experience- everyday life with chronic sensory disturbances after oxaliplatin treatment for colorectal cancer - a phenomenological study. Int J Qual Stud Health Well-being. 2021; 16(1):1950889. PMC: 8317951. DOI: 10.1080/17482631.2021.1950889. View

20.

Jensen M, Morch C, Yilmaz M, Feilberg C, Pedersen B . A new self-understanding as chemo sufferer - a phenomenological study of everyday life with chemotherapy induced neuropathy among survivors after colorectal cancer. Int J Qual Stud Health Well-being. 2022; 17(1):2049437. PMC: 8942531. DOI: 10.1080/17482631.2022.2049437. View